NASDAQ:AUPH
Aurinia Pharmaceuticals Inc Stock News
$5.76
-0.0100 (-0.173%)
At Close: May 17, 2024
Aurinia Presents Aurora Pivotal Trial Subgroup Analysis At The Eular 2020 E-Congress
11:08am, Friday, 05'th Jun 2020Aurinia Presents AURORA Pivotal Trial Subgroup Analysis at the EULAR 2020 E-Congress
11:05am, Friday, 05'th Jun 2020
Aurinia Pharmaceuticals Inc. (Nasdaq:AUPH / TSX:AUP) ("Aurinia" or the "Company"), a late-stage clinical biopharmaceutical company focused on advancing voclosporin across multiple indications, announc
Biotech Stocks: Buy This, Not That
10:34am, Thursday, 04'th Jun 2020
A crucial aspect of success in investing in biotech stocks is that of timing. Buying a stock too early can mean enduring infinite dilution and clinical trial failures before a company can finally bri
Aurinia Announces Results of Annual General Meeting
10:05am, Wednesday, 03'rd Jun 2020
Aurinia Pharmaceuticals Inc. (Nasdaq: AUPH / TSX: AUP) ("Aurinia" or the "Company") is pleased to announce that the nine incumbent directors of the Company were elected at the Company’s annual gener
Aurinia Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference
08:05pm, Monday, 01'st Jun 2020
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX: AUP) (the "Company") today announced that Peter Greenleaf, President and Chief Executive Officer of Aurinia, will participate in a fireside chat durin
Aurinia Submits FDA New Drug Admission For Novel Voclosporin Kidney Treatment
12:16pm, Tuesday, 26'th May 2020
Shares in Aurinia Pharmaceuticals, Inc (AUPH) advanced in pre-market trading as the biotech company announced the submission of the New Drug Application (NDA) for its experimental voclosporin drug for
Aurinia Completes Submission Of New Drug Application To FDA For Voclosporin For The Treatment Of Lupus Nephritis
10:06am, Tuesday, 26'th May 2020
Aurinia Pharmaceuticals Inc. (Nasdaq:AUPH / TSX:AUP) ("Aurinia" or the "Company"), a late-stage clinical biopharmaceutical company focused on advancing voclosporin across multiple indications, today a
Billionaire Jim Simons Pulls the Trigger on These 3 Healthcare Stocks
02:04pm, Wednesday, 20'th May 2020
Despite COVID-19's devastating impact, one legendary stock picker might have just cracked the market code. While the broader market tumbled, investing firm Renaissance Technologies and its founder Jim
Aurinia Pharmaceuticals Inc (AUPH) Q1 2020 Earnings Call Transcript
08:26pm, Tuesday, 19'th May 2020
AUPH earnings call for the period ending March 31, 2020.
Aurinia Pharmaceuticals Inc. (TSE:AUP) Released Earnings Last Week And Analysts Lifted Their Price Target To US$32.00
10:10am, Tuesday, 19'th May 2020
Shareholders might have noticed that Aurinia Pharmaceuticals Inc. (TSE:AUP) filed its first-quarter result this time...
Aurinia Pharmaceuticals to Present at 2020 RBC Capital Markets’ Virtual Global Healthcare Conference
08:05pm, Friday, 15'th May 2020
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX: AUP) (the "Company") today announced that Peter Greenleaf, President and Chief Executive Officer of Aurinia, will participate in a fireside chat durin
HealthCor Management, L.P. Buys Encompass Health Corp, ACADIA Pharmaceuticals Inc, Haemonetics ...
12:00am, Friday, 15'th May 2020Aurinia Pharmaceuticals (AUPH) Reports Q1 Loss, Misses Revenue Estimates
09:35pm, Thursday, 14'th May 2020
Aurinia (AUPH) delivered earnings and revenue surprises of 25.00% and -50.00%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
